A pharmaceutical firm based in Utah has been working to change the course of Alzheimer’s Disease.
On the occasion of the 100th anniversary of the first report of dementia by Dr. Alois Alzheimer’s, this drug company, a few years back, supported two innovative programs that were designed to utilize art and science as a way to inspire and inform the public about Alzheimer’s Disease. Both of these initiatives were hosted by Alzheimer’s Association- New York City Chapter and were held at the New York Academy of Medicine in New York City.
The art exhibition entitled The Later Works of William Utermohlen 1995-2000 that showcased a series of self portrait by the artist after he was diagnosed with Alzheimer’s Disease in 1995. These pictures visually communicate the emotional, perceptual, and psychological journey of a man living with Alzheimer’s disease.
Despite the great sadness these works evoke, they are surely Bill’s most compelling works. They remain a testimony to the creative and human spirit that resides in many people with Alzheimer’s Disease.
(Text and photos lifted from the commemorative DVD given out by Myriad Pharmaceuticals at an international Alzheimer’s congress. Use of the material for this post is for information and advocacy purposes)